Analyst Activity – Royal Bank Of Canada Raises Its Price Target On Intercept Pharmaceuticals (NASDAQ:ICPT) to $244.00

ME Staff
-
0

Analyst Ratings For Intercept Pharmaceuticals (NASDAQ:ICPT)

Today, Royal Bank Of Canada raised its price target on Intercept Pharmaceuticals (NASDAQ:ICPT) to $244.00 per share.

There are 2 sell ratings, 7 hold ratings, 7 buy ratings on the stock.

The current consensus rating on Intercept Pharmaceuticals (NASDAQ:ICPT) is Hold (Score: 2.31) with a consensus target price of $177.69 per share, a potential 190.20% upside.

Some recent analyst ratings include

  • 9/23/2017-Robert W. Baird Reiterated Rating of Outperform.
  • 9/23/2017-Leerink Swann Reiterated Rating of Market Perform.
  • 9/22/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform .
  • 9/22/2017-BMO Capital Markets Reiterated Rating of Outperform.
  • 9/22/2017-Morgan Stanley Reiterated Rating of Underweight.
  • 9/22/2017-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Intercept Pharmaceuticals (NASDAQ:ICPT)
Intercept Pharmaceuticals (NASDAQ:ICPT) has insider ownership of 4.50% and institutional ownership of 82.19%.

  • On 9/1/2017 David Shapiro, CMO, sold 1,250 with an average share price of $117.43 per share and the total transaction amounting to $146,787.50. View SEC Filing
  • On 8/25/2017 Lisa Bright, Insider, sold 253 with an average share price of $111.31 per share and the total transaction amounting to $28,161.43. View SEC Filing
  • On 8/2/2017 Lisa Bright, Insider, sold 142 with an average share price of $110.29 per share and the total transaction amounting to $15,661.18. View SEC Filing
  • On 8/1/2017 David Shapiro, CMO, sold 1,118 with an average share price of $119.00 per share and the total transaction amounting to $133,042.00. View SEC Filing
  • On 7/31/2017 Daniel G Welch, Director, sold 602 with an average share price of $123.93 per share and the total transaction amounting to $74,605.86. View SEC Filing
  • On 7/31/2017 Rachel Mcminn, Insider, sold 130 with an average share price of $123.12 per share and the total transaction amounting to $16,005.60. View SEC Filing
  • On 7/20/2017 Daniel G Welch, Director, sold 217 with an average share price of $126.76 per share and the total transaction amounting to $27,506.92. View SEC Filing

Recent Trading Activity for Intercept Pharmaceuticals (NASDAQ:ICPT)
Shares of Intercept Pharmaceuticals closed the previous trading session at with shares trading hands.